Compositions comprising decarboxylated cannabinoids

A capsule or tablet composition comprising:

• cellulose I;
• decarboxylated cannabinoids;
• and
• nucleic acids encoding a geranyl-pyrophosphate-olivetolic acid geranyltransferase and/or a geranyl-pyrophosphate-olivetolic acid geranyltransferase protein;
• wherein:
• the capsule or tablet comprises at least 5 and no greater than 50 milligrams of one or more of the decarboxylated cannabinoids;
• the decarboxylated cannabinoids comprise one or more of cannabidiol, cannabidivarin, tetrahydrocannabinol, tetrahydrocannabivarin, and cannabigerol;
• the composition comprises the decarboxylated cannabinoids at a combined concentration of at least 0.5 percent and no greater than 5 percent by weight;
• and
• the composition lacks cannabidiolic acid, cannabidivarin acid, tetrahydrocannabinolic acid, tetrahydrocannabivarin acid, and cannabigerolic acid at a combined concentration greater than 1 percent by weight;
• wherein said composition further comprises:
• either bicyclohumuladiol or a stereoisomer of bicyclohumuladiol at a concentration of at least 0.1 and no greater than 1000 parts per million by weight;
• either tricyclohumuladiol or a stereoisomer of tricyclohumuladiol at a concentration of at least 0.1 and no greater than 1000 parts per million by weight;
• and/or
• either tricyclohumuladiol II or a stereoisomer of tricyclohumuladiol II at a concentration of at least 0.1 and no greater than 1000 parts per million by weight (italicized for added emphasis).